Simultaneous analysis of cytochrome P450 probes-dextromethorphan, flurbiprofen and midazolam and their major metabolites by HPLC-mass-spectrometry/fluorescence after single-step extraction from plasma

Atul Kumar, Henry J. Mann, Rory P Remmel

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Cytochrome P450 enzymes catalyze oxidative metabolism of most pharmaceutical compounds. Consequently dextromethorphan, flurbiprofen, midazolam and other compounds are commonly used as probe substrates to evaluate cytochrome P450 function in humans. A "cocktail" approach employing simultaneous administration of two or more of the probe substrates has been used by various investigators in recent years. An analytical strategy to simultaneously extract and analyze dextromethorphan, flurbiprofen and midazolam and their major metabolites (dextrorphan, 4′-hydroxy-flurbiprofen and 1′-hydroxy-midazolam) by HPLC-MS/fluorescence was developed and is described here. The three probe substrates and their major metabolites were extracted simultaneously by means of a solid-phase (Bond Elut Certify ® cartridges) extraction procedure from 200 μl of pig plasma. The extraction efficiency was more than 79.5% for each of the six analytes. The extracted compounds were chromatographically separated on a Luna C8(II) column (50 mm L × 3 mm ID) in a single run of 20 min and analyzed by either fluorescence (flurbiprofen and 4′-hydroxy-flurbiprofen) or selective ion monitoring (dextromethorphan, dextrorphan, midazolam and 1′-hydroxy-midazolam) with positive electrospray ionization. The limit of quantification was 2.5 ng/ml for midazolam and 5 ng/ml for the other five analytes. The assay was precise and accurate (error: -9.1 to 12.1) with total CVs of 13.9% or better for each of the 6 analytes. This method was used to analyze concentrations of the three probes and their metabolites in plasma after intravenous administration to a healthy pig.

Original languageEnglish (US)
Pages (from-to)287-293
Number of pages7
JournalJournal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Volume853
Issue number1-2
DOIs
StatePublished - Jun 15 2007

Fingerprint

Dextromethorphan
Flurbiprofen
Midazolam
Metabolites
Cytochrome P-450 Enzyme System
Mass spectrometry
Mass Spectrometry
Fluorescence
High Pressure Liquid Chromatography
Plasmas
Dextrorphan
Substrates
Swine
Electrospray ionization
Metabolism
Intravenous Administration
Assays
Research Personnel
Ions
Monitoring

Keywords

  • Cytochrome P450
  • Dextromethorphan
  • Flurbiprofen
  • LC/MS
  • Midazolam
  • Pharmacokinetics
  • Phenotyping
  • Pig

Cite this

@article{3eeb249f09fa450d94c613cc9a93b099,
title = "Simultaneous analysis of cytochrome P450 probes-dextromethorphan, flurbiprofen and midazolam and their major metabolites by HPLC-mass-spectrometry/fluorescence after single-step extraction from plasma",
abstract = "Cytochrome P450 enzymes catalyze oxidative metabolism of most pharmaceutical compounds. Consequently dextromethorphan, flurbiprofen, midazolam and other compounds are commonly used as probe substrates to evaluate cytochrome P450 function in humans. A {"}cocktail{"} approach employing simultaneous administration of two or more of the probe substrates has been used by various investigators in recent years. An analytical strategy to simultaneously extract and analyze dextromethorphan, flurbiprofen and midazolam and their major metabolites (dextrorphan, 4′-hydroxy-flurbiprofen and 1′-hydroxy-midazolam) by HPLC-MS/fluorescence was developed and is described here. The three probe substrates and their major metabolites were extracted simultaneously by means of a solid-phase (Bond Elut Certify {\circledR} cartridges) extraction procedure from 200 μl of pig plasma. The extraction efficiency was more than 79.5{\%} for each of the six analytes. The extracted compounds were chromatographically separated on a Luna C8(II) column (50 mm L × 3 mm ID) in a single run of 20 min and analyzed by either fluorescence (flurbiprofen and 4′-hydroxy-flurbiprofen) or selective ion monitoring (dextromethorphan, dextrorphan, midazolam and 1′-hydroxy-midazolam) with positive electrospray ionization. The limit of quantification was 2.5 ng/ml for midazolam and 5 ng/ml for the other five analytes. The assay was precise and accurate (error: -9.1 to 12.1) with total CVs of 13.9{\%} or better for each of the 6 analytes. This method was used to analyze concentrations of the three probes and their metabolites in plasma after intravenous administration to a healthy pig.",
keywords = "Cytochrome P450, Dextromethorphan, Flurbiprofen, LC/MS, Midazolam, Pharmacokinetics, Phenotyping, Pig",
author = "Atul Kumar and Mann, {Henry J.} and Remmel, {Rory P}",
year = "2007",
month = "6",
day = "15",
doi = "10.1016/j.jchromb.2007.03.032",
language = "English (US)",
volume = "853",
pages = "287--293",
journal = "Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences",
issn = "1570-0232",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Simultaneous analysis of cytochrome P450 probes-dextromethorphan, flurbiprofen and midazolam and their major metabolites by HPLC-mass-spectrometry/fluorescence after single-step extraction from plasma

AU - Kumar, Atul

AU - Mann, Henry J.

AU - Remmel, Rory P

PY - 2007/6/15

Y1 - 2007/6/15

N2 - Cytochrome P450 enzymes catalyze oxidative metabolism of most pharmaceutical compounds. Consequently dextromethorphan, flurbiprofen, midazolam and other compounds are commonly used as probe substrates to evaluate cytochrome P450 function in humans. A "cocktail" approach employing simultaneous administration of two or more of the probe substrates has been used by various investigators in recent years. An analytical strategy to simultaneously extract and analyze dextromethorphan, flurbiprofen and midazolam and their major metabolites (dextrorphan, 4′-hydroxy-flurbiprofen and 1′-hydroxy-midazolam) by HPLC-MS/fluorescence was developed and is described here. The three probe substrates and their major metabolites were extracted simultaneously by means of a solid-phase (Bond Elut Certify ® cartridges) extraction procedure from 200 μl of pig plasma. The extraction efficiency was more than 79.5% for each of the six analytes. The extracted compounds were chromatographically separated on a Luna C8(II) column (50 mm L × 3 mm ID) in a single run of 20 min and analyzed by either fluorescence (flurbiprofen and 4′-hydroxy-flurbiprofen) or selective ion monitoring (dextromethorphan, dextrorphan, midazolam and 1′-hydroxy-midazolam) with positive electrospray ionization. The limit of quantification was 2.5 ng/ml for midazolam and 5 ng/ml for the other five analytes. The assay was precise and accurate (error: -9.1 to 12.1) with total CVs of 13.9% or better for each of the 6 analytes. This method was used to analyze concentrations of the three probes and their metabolites in plasma after intravenous administration to a healthy pig.

AB - Cytochrome P450 enzymes catalyze oxidative metabolism of most pharmaceutical compounds. Consequently dextromethorphan, flurbiprofen, midazolam and other compounds are commonly used as probe substrates to evaluate cytochrome P450 function in humans. A "cocktail" approach employing simultaneous administration of two or more of the probe substrates has been used by various investigators in recent years. An analytical strategy to simultaneously extract and analyze dextromethorphan, flurbiprofen and midazolam and their major metabolites (dextrorphan, 4′-hydroxy-flurbiprofen and 1′-hydroxy-midazolam) by HPLC-MS/fluorescence was developed and is described here. The three probe substrates and their major metabolites were extracted simultaneously by means of a solid-phase (Bond Elut Certify ® cartridges) extraction procedure from 200 μl of pig plasma. The extraction efficiency was more than 79.5% for each of the six analytes. The extracted compounds were chromatographically separated on a Luna C8(II) column (50 mm L × 3 mm ID) in a single run of 20 min and analyzed by either fluorescence (flurbiprofen and 4′-hydroxy-flurbiprofen) or selective ion monitoring (dextromethorphan, dextrorphan, midazolam and 1′-hydroxy-midazolam) with positive electrospray ionization. The limit of quantification was 2.5 ng/ml for midazolam and 5 ng/ml for the other five analytes. The assay was precise and accurate (error: -9.1 to 12.1) with total CVs of 13.9% or better for each of the 6 analytes. This method was used to analyze concentrations of the three probes and their metabolites in plasma after intravenous administration to a healthy pig.

KW - Cytochrome P450

KW - Dextromethorphan

KW - Flurbiprofen

KW - LC/MS

KW - Midazolam

KW - Pharmacokinetics

KW - Phenotyping

KW - Pig

UR - http://www.scopus.com/inward/record.url?scp=34250023220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250023220&partnerID=8YFLogxK

U2 - 10.1016/j.jchromb.2007.03.032

DO - 10.1016/j.jchromb.2007.03.032

M3 - Article

C2 - 17452028

AN - SCOPUS:34250023220

VL - 853

SP - 287

EP - 293

JO - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

JF - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

SN - 1570-0232

IS - 1-2

ER -